JUPITER THERAPEUTICS, INC. — National Science Foundation SBIR Phase I: PT
JUPITER THERAPEUTICS, INC. — SBIR Phase I award from National Science Foundation.
- Amount
- $255,961
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- PT
- NAICS
- —
- Place of performance
- CA
- Period
- 2020-09-15 → 2021-08-31
Description
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide a novel treatment option for COVID-19 patients with life-threatening medical complications. Coronavirus infection causes inflammatory r